Free Trial

Cardlytics (CDLX) Projected to Post Quarterly Earnings on Wednesday

Cardlytics logo with Business Services background
Remove Ads

Cardlytics (NASDAQ:CDLX - Get Free Report) is anticipated to post its Q4 2024 quarterly earnings results after the market closes on Wednesday, March 12th. Analysts expect Cardlytics to post earnings of ($0.24) per share and revenue of $63.63 million for the quarter. Investors that are interested in participating in the company's conference call can do so using this link.

Cardlytics Trading Up 4.8 %

Cardlytics stock traded up $0.10 during trading hours on Thursday, reaching $2.08. 5,930,317 shares of the company's stock were exchanged, compared to its average volume of 1,100,090. The firm's 50 day simple moving average is $3.06 and its 200 day simple moving average is $3.51. Cardlytics has a twelve month low of $1.77 and a twelve month high of $20.52. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. The firm has a market capitalization of $105.46 million, a PE ratio of -0.34 and a beta of 1.62.

Analyst Ratings Changes

A number of research firms have issued reports on CDLX. Evercore ISI cut their price target on Cardlytics from $4.00 to $3.00 and set an "in-line" rating on the stock in a report on Thursday. Needham & Company LLC reissued a "hold" rating on shares of Cardlytics in a research note on Thursday. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Cardlytics presently has an average rating of "Hold" and a consensus target price of $6.75.

Remove Ads

Check Out Our Latest Stock Analysis on Cardlytics

Insider Buying and Selling at Cardlytics

In other Cardlytics news, CFO Alexis Desieno sold 24,778 shares of Cardlytics stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $84,245.20. Following the transaction, the chief financial officer now owns 140,948 shares of the company's stock, valued at $479,223.20. This trade represents a 14.95 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Amit Gupta sold 46,857 shares of the stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $159,313.80. Following the sale, the chief executive officer now directly owns 418,637 shares of the company's stock, valued at $1,423,365.80. The trade was a 10.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 111,454 shares of company stock worth $391,864. Insiders own 4.40% of the company's stock.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Read More

Earnings History for Cardlytics (NASDAQ:CDLX)

Should You Invest $1,000 in Cardlytics Right Now?

Before you consider Cardlytics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardlytics wasn't on the list.

While Cardlytics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads